Jefferies analysts forecast a $1 billion market opportunity for each of Sarepta’s siRNA programs for facioscapulohumeral ...

Novartis has significantly strengthened its neuroscience pipeline over recent years, topped by the $12bn acquisition of ...

Axial myopathy is a general term for a group of myopathies affecting the axial muscles. Axial myopathy appears to be a grossly underestimated feature of many muscle diseases and often overlooked ...